alexa The middle molecule hypothesis in perspective.
Pharmaceutical Sciences

Pharmaceutical Sciences

Journal of Bioequivalence & Bioavailability

Author(s): Babb AL, Ahmad S, Bergstrm J, Scribner BH

Abstract Share this page

Abstract The middle molecule (MM) hypothesis states that molecules in the molecular weight range of 500 to 2000 daltons/molecule accumulate in uremia and are one cause of peripheral neuropathy. Evidence for and against this hypothesis is reviewed and evaluated. The course of events in the core of early hemodialysis patients who developed neuropathy provides important support ofr the hypothesis. Failure of early peritoneal dialysis patients to develop neuropathy suggested that the peritoneum is more permeable to MM's than early hemodialysis membranes, a fact that was later hemodialysis membranes, a fact that was later confirmed by appropriate investigations. Several investigators have demonstrated that MM's actually do accumulate in uremia and disappear rapidly following a renal transplant, which suggests a high clearance by the human kidney. Retrospective and prospective studies have demonstrated a protective effect of residual renal function against MM intoxication. Our prospective studies to produce MM intoxication are reviewed and their strengths and weaknesses delineated. Similarly, the investigations of others that are cited as evidence against the MM hypothesis are reviewed. It is the opinion of hte authors that the weight of evidence supports the validity of the MM hypothesis; but that final proof still is lacking. A protocol for more definitive studies is discussed.
This article was published in Am J Kidney Dis and referenced in Journal of Bioequivalence & Bioavailability

Relevant Expert PPTs

Relevant Speaker PPTs

Recommended Conferences

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords